Effect of perinatally acquired human immunodeficiency virus infection on neurodevelopment in children during the first two years of life
- PMID: 7971006
Effect of perinatally acquired human immunodeficiency virus infection on neurodevelopment in children during the first two years of life
Abstract
Objective: To determine the timing, extent, and magnitude of neurodevelopmental problems in children with perinatal HIV infection compared to similar uninfected children of HIV-infected women and controls.
Methods: Neurodevelopmental assessments during the first 24 months of life for 21 HIV-infected children born to HIV-infected mothers, 65 seroreverted children born to HIV-infected mothers, and 95 non-HIV-infected children born to non-HIV-infected mothers were analyzed. Neurodevelopment was assessed by using the Bayley Scales of Infant Development beginning at 3 months of age. Kent Scoring Adaptation was also utilized. A two-stage Hierarchical Linear Model was used for analysis of neurodevelopmental scores.
Results: In the initial comparison of these three groups, infected children had significantly lower scores on the Mental Development Index (MDI) and Psychomotor Development Index (PDI) than the other two groups. The HIV-infected children were further classified into HIV-infected without Centers for Disease Control-defined AIDS, those with lymphoid interstitial pneumonitis (LIP) only as their AIDS-defining illness, and children with an AIDS-defining diagnosis other than LIP in the first 24 months. The children with LIP-only AIDS and the infected children without AIDS on average were not significantly different from the seroreverters or the controls on MDI or PDI, while the children with non-LIP AIDS had significantly lower scores after 3 months of age. Analysis of the Kent scores indicated that the decrement in the non-LIP AIDS children was seen in all five functional domains.
Conclusion: Children with serious HIV symptomatology appear to be at very high risk for serious developmental impairments, HIV-infected children not highly symptomatic have relatively normal neurodevelopment, and uninfected children of HIV-infected mothers do not appear to be adversely affected by the mother's HIV infection.
Similar articles
-
Neurologic status of human immunodeficiency virus 1-infected infants and their controls: a prospective study from birth to 2 years. Mothers and Infants Cohort Study.Pediatrics. 1996 Dec;98(6 Pt 1):1109-18. Pediatrics. 1996. PMID: 8951261 Clinical Trial.
-
A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.Pediatrics. 2006 Oct;118(4):e1139-45. doi: 10.1542/peds.2006-0525. Epub 2006 Aug 28. Pediatrics. 2006. PMID: 16940166
-
Neurodevelopmental testing of children born to human immunodeficiency virus type 1 seropositive and seronegative mothers: a prospective cohort study in Kigali, Rwanda.Pediatrics. 1993 Dec;92(6):843-8. Pediatrics. 1993. PMID: 8233747
-
Pediatric AIDS and perinatal HIV infection in Zaire: epidemiologic and pathologic findings.Prog AIDS Pathol. 1992;3(1):1-33. Prog AIDS Pathol. 1992. PMID: 1606299 Review.
-
Human immunodeficiency virus infection in children: nature of immunodeficiency, clinical spectrum and management.Pediatr Infect Dis J. 1988 May;7(5 Suppl):S61-71. Pediatr Infect Dis J. 1988. PMID: 3041360 Review.
Cited by
-
Building capacity in neurodevelopment assessment of children in sub-Saharan Africa: A quality assurance model to implement standardized neurodevelopment testing.Child Neuropsychol. 2019 May;25(4):466-481. doi: 10.1080/09297049.2018.1497588. Epub 2018 Aug 14. Child Neuropsychol. 2019. PMID: 30105934 Free PMC article.
-
Early immunological predictors of neurodevelopmental outcomes in HIV-infected children.Clin Infect Dis. 2009 Feb 1;48(3):338-46. doi: 10.1086/595885. Clin Infect Dis. 2009. PMID: 19115969 Free PMC article.
-
Maternal HIV and drug use: effect on health and social morbidity.Arch Dis Child. 1996 Mar;74(3):210-4. doi: 10.1136/adc.74.3.210. Arch Dis Child. 1996. PMID: 8787424 Free PMC article.
-
Neurodevelopmental benefits of antiretroviral therapy in Ugandan children aged 0-6 years with HIV.J Acquir Immune Defic Syndr. 2014 Nov 1;67(3):316-22. doi: 10.1097/QAI.0000000000000295. J Acquir Immune Defic Syndr. 2014. PMID: 25314252 Free PMC article.
-
Impact of HIV severity on cognitive and adaptive functioning during childhood and adolescence.Pediatr Infect Dis J. 2012 Jun;31(6):592-8. doi: 10.1097/INF.0b013e318253844b. Pediatr Infect Dis J. 2012. PMID: 22592486 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical